Fate Therapeutics Inc. buy melinda
Start price
11.05.17
/
50%
€3.63
Target price
30.10.17
€4.15
Performance (%)
14.68%
End price
30.10.17
€4.16
Summary
This prediction ended on 30.10.17 with a price of €4.16. The prediction had a final performance of 14.68%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | 17.019% | 17.019% | -15.815% | -79.580% |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% | 60.124% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% | 101.416% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% | 47.915% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% | 64.215% |
Comments by melinda for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
Stopped prediction by melinda for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.80
02.10.20
02.10.20
€38.00
04.11.21
04.11.21
54.39%
05.11.21
05.11.21
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.88
17.03.19
17.03.19
€18.04
22.04.19
22.04.19
-15.13%
22.04.19
22.04.19